Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube

SCAI publishes expert consensus statement on calcified coronary lesions

A newly published Soc...

Philips’ “mini” 3D TEE transducer granted US FDA approval

Royal Philips has receive...
TRIOMPHE

Endospan releases early TRIOMPHE IDE study results at STS 2024

Endospan shared 30-da...

STS 2024: STS elects its first female president

Jennifer C Romano has...

STS 2024: Data show shift in the proportion of patients under 60 receiving TAVI instead of SAVR

Research presented at...

French registry study finds fewer cardiovascular deaths among mitral regurgitation patients receiving TEER

The results of a propensi...

Early feasibility study of CroíValve’s Duo tricuspid coaptation valve system launches

CroíValve has announced t...

Simona Zannetti returns to Medtronic to lead aortic business

Medtronic recently an...

Collaboration aims to develop a bespoke cell phenotyping assay for human blood

PlaqueTec, a company iden...

Three valve-in-valve procedures completed using DurAVR transcatheter valve

Anteris Technologies has ...

US FDA grants breakthrough designation for Pi-Cardia’s ShortCut leaflet splitting device

Pi-Cardia has received br...

See the full shortlist for the Global Cardiovascular Awards

The full shortlist for th...

First-in-human implant of Triflo heart valve completed

Novostia has announced th...

Radiofrequency renal denervation meets cost efficiency threshold in value analysis

An analysis of data f...

FastWave Medical announces completion of first procedures in study of novel peripheral IVL system

FastWave Medical has ...

Study shows no safety risk in allowing patients to eat prior to cardiac catherisation

Allowing patients to eat ...

“Structural heart leader” joins Cardiac Dimensions as chief medical officer

Cardiac Dimensions, a...

Penumbra launches Indigo system CAT RX catheter in Europe to treat acute coronary syndrome

Penumbra has secured CE m...

Occlutech to launch atrial septal defect occluder in the USA

Occlutech has announced t...

US FDA grants clearance for VR surgical planning software from Realize Medical

Realize Medical has annou...

First patient randomised in BACKBEAT study of AVIM therapy for uncontrolled hypertension

Orchestra BioMed Holdings...

US FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system

Endovascular Engineering ...

Medical cannabis for chronic pain may increase risk of arrhythmia

People taking medical...

Cook Medical announces Slip-Cath Beacon Tip catheter is now available in the USA and Canada

Cook Medical has anno...

SCAI, SIR, SVS jointly publish proceedings from multispecialty peripheral IVUS roundtable

Proceedings from an e...

GE HealthCare to acquire AI-imaging specialist

GE HealthCare has entered...

R-One robotic platform given green light to enter Chinese market

Robocath has announced th...

Endotronix submits premarket approval application to US FDA for Cordella pulmonary artery sensor

Endotronix has submit...

Edwards Lifesciences appoints its first US case observation site under Benchmark TAVI programme

Eisenhower Health (Ra...

Topaz tricuspid valve replacement system used for the first time in a patient with a pacemaker

TRiCares SAS has announce...

Chilean centre treats five aortic regurgitation patients in a single day with Zeta TAVI system

Laguna Tech USA has annou...

HeartFlow’s FFRCT analysis passes 250,000 patient milestone

HeartFlow, a develope...

Pulse Biosciences files premarket US FDA 510(k) notification for its CellFX nsPFA cardiac clamp

Pulse Biosciences has fil...

Investors offer backing for developer of transcatheter mitral chord repair technology

Norway-based CardioMe...

First patient treated in ARISE II study of Gore ascending stent graft

Gore has announced the fi...

Cardiovascular News’ top stories of 2023

Which stories, features a...

Blood potassium monitor under development to benefit patients with chronic renal failure

CardioRenal and CHU Greno...

LUMA Vision secures US$22 million in financing

LUMA Vision, develope...

CE mark trial of Optimum TAVI valve given green light for expansion

Thubrikar Aortic Valve ha...

Microbot Medical and Corewell Health announce telerobotics collaboration

Microbot Medical, develop...

Early use of mechanical support shows benefit for patients with AMI complicated by cardiogenic shock

Results of the National C...

ANGIODAPT trial launches with first patient enrolment

iVascular has announced t...

First-in-man cross-country robotic coronary angioplasty performed in two Chinese centres

Robocath has announced a ...

First patient treated with PerQseal Elite vascular closure system

Vivasure Medical has anno...

Haemonetics completes acquisition of OpSens

Haemonetics Corporation h...

Consortium to assess use of CT to improve diagnosis and treatment of coronary artery disease

A public-private partners...

Mortality from cardiovascular disease continues to increase globally

Cardiovascular diseases, ...

Pi-Cardia appoints Gary Gratson to lead commercialisation of ShortCut

Pi-Cardia has appoint...

Warfarin lowers mortality risk after SAVR

Patients who received war...

Harlan M Krumholz named as JACC editor-in-chief

The cardiologist and ...

Projected rise in aortic valve-in-valve procedures prompts interest in leaflet splitting device

Details of the first ...

Catheter Precision’s VIVO 3D mapping system secures reimbursement in NHS England’s SSDP

Healthcare 21 (HC21) has ...

Kaneka Corporation acquires Japan Medical Device Technology Co

Kaneka Corporation has ac...

Profiling plaque to guide treatment of coronary artery disease

Investigators behind ...

Carmat increases capacity with opening of second production facility

Carmat has opened a secon...

Medtronic launches Penditure left atrial appendage exclusion system in the USA

Medtronic has announc...

First patients join pivotal trial of Aortix pump for treatment of acute decompensated heart failure

Procyrion has announc...

Johnson & Johnson acquires Laminar

Johnson & Johnson Med...

Next-generation Palmetto TMVR system gets first-in-man use

ReValve Solutions has ann...

Bivacor gets US FDA nod for early feasibility of its total artificial heart

The US Food and Drug Admi...

BIOPATTERN trial seeks precision approach to coronary artery disease treatment

PlaqueTec has receive...

Inari Medical announces first patient enrolment in PEERLESS II randomised controlled trial

Inari Medical has annou...
Tria

Enrolment in Indian clinical trial of Tria mitral valve completed

Foldax has announced ...

First patient enrolled in RECOVER IV randomised trial of Impella in AMI patients

Abiomed has announced tha...

AF after mitral valve surgery “has a strong negative influence on survival”

The occurrence of atrial ...

EACTS panel sounds call to action over sex disparities in coronary surgery

A historic underrepre...

Low-risk TAVI trials underscore optimism for transcatheter approach but surgical societies reserve caution

“It has been a good d...

Death rates after CABG and other surgeries “similar” regardless of patient-surgeon gender concordance

Death rates after major s...

Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ

A comparison of two l...

AI-derived risk score may improve planning of TEER for secondary mitral regurgitation

A novel risk score de...

SCAI: First US renal denervation approvals “revolutionise” treatment of uncontrolled hypertension

The approval of two renal...

Supira Medical to initiate US clinical programme for pVAD system

Supira Medical announ...

Roadmap launched to guide shared decision-making in heart valve disease treatment

Global Heart Hub, an inte...

Medtronic’s Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment

Medtronic has announced a...

JenaValve partners with American Society of Echocardiography to increase awareness of aortic regurgitation

JenaValve Technology has ...

ADVERTORIAL: NOTION trial results crystallise long-term thinking on TAVI versus SAVR

This advertorial is spons...

Jolanda Kluin

Inspired by a passion for...

Cardiovascular News – Issue 71 – November 2023: OUS Edition

In this issue: Low-r...

Cardiovascular News – Issue 71 – November 2023: US Edition

In this issue: Low-r...

ARIES trial shows LVAD patients who did not receive aspirin had fewer bleeding complications

Abbott has announced ...

ACCESS-MANTA registry to assess use of Manta vascular closure device in TAVI procedures

Teleflex has announced th...

TRANSFORM trial to explore personalised strategy for cardiovascular disease prevention

Cleerly has announced...
VOYAGER

VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations

New analyses from the...

First-in-human study explores safety and feasibility of Captis embolic protection device during TAVI procedures

Filterlex Medical has...

EECP therapy results “promising” for ANOCA patients

Enhanced external cou...

PATCH clinical study of PerQseal vascular closure system reaches 100-patient milestone

Vivasure Medical has ...

First-in-human results of non-invasive ultrasound therapy for aortic stenosis published in The Lancet

Results from first-in-hum...

First implant of ChordArt TMVR system completed

CoreMedic has announced t...

AHA 2023: RCE Technologies wins Health Tech competition

RCE Technologies, the...

SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide

Results of the SELECT cli...

Xenter unveils dual-sensor TAVI guidewire

Xenter unveiled its dual ...

PCI improves angina symptoms without medication in ORBITA-2 trial

Percutaneous coronary...

Revascularisation considered over amputation for CLTI in UK, new study states

A new study published...

Data and debate to bring new light to aortic controversies at CX 2024

The aortic programme at t...

Medinbox launches latest proctoring and remote learning platform for cath labs

Medinbox has launched...

Scott Drake appointed as Cordis CEO

Cordis has announced ...

Recor Medical gains first US FDA renal denervation approval

Recor Medical has bec...

CONFORMAL EFS results shared out to one year at TCT 2023

Conformal Medical has...

No difference in outcomes for AF patients undergoing LAAO and TAVI at the same time

Patients with atrial ...

REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical thrombectomy for PE treatment

Data from the REAL-PE...
STRIKE-PE

Late breaking STRIKE-PE data shows improved outcomes for pulmonary embolism patients

Penumbra, a global he...

Surmodics launches Preside hydrophilic coatings for neurovascular, coronary and peripheral applications

Surmodics has announced t...

E2 shares positive initial results from use of Hēlo system for acute sub-massive pulmonary embolism treatment

Endovascular Engineering ...

First patients enrolled in coronary de novo trial of Selution SLR drug-eluting balloon

Cordis has announced enro...

Study provides insights from US cohort of FLASH registry for high-risk PE

New research from the...

TCT 2023: TAVI system for aortic regurgitation shows promise in ALIGN AR trial

Positive results from...

First patients treated with Laguna Tech’s Alpha and Zeta aortic valves

Laguna Tech USA has annou...

Edwards Lifesciences’ Mitris Resilia valve receives CE mark for mitral replacement surgeries

Edwards Lifesciences has ...

TCT 2023: TRILUMINATE quality of life data point to benefit for patients with severe TR undergoing TEER

Analysis of health st...

TCT 2023: Initial phase of TRISCEND II trial of Evoque transcatheter replacement for severe tricuspid regurgitation meets primary endpoints

A randomised trial co...

TCT 2023: Agent DCB shows superiority to conventional balloon angioplasty for target-lesion failure in US randomised trial

The first US randomis...

TCT 2023: Five-year PARTNER 3 results “reaffirm” role of TAVI as alternative to surgery in low-risk patients

Five-year data from t...

TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough for below-the-knee arteries

Results of the LIFE-B...

TCT 2023: Intellistent multi-lumen stent system for pulmonary arterial hypertension wins Shark Tank innovation prize

HeartPoint Global was nam...

Medinol’s EluNIR-PERL coronary stent gains US FDA approval

Medinol today announc...

TCT 2023: EVOLUT Low Risk trial shows continued strong performance for self-expanding TAVI platform out to four years

At four years of foll...

TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped sway the US FDA

Data from a patient-l...

GE HealthCare’s Allia IGS Pulse imaging system approved by the US FDA

GE HealthCare has announc...

RELIEF clinical study of PFO closure for migraine relief begins randomisation

Patients have passed ...

Multicentre study points to favourable safety and efficacy of radial access for peripheral interventions

New research examinin...

Site-less model helps to improve diversity in PREVUE-VALVE study

Researchers behind a tria...

Medtronic receives CE mark for Evolut FX TAVI system to treat severe aortic stenosis

Medtronic has received CE...

EACTS 2023: Registry study finds “significantly increased” all-cause mortality among older patients selected for TAVI versus SAVR

A population-based co...

OpSens and Haemonetics enter into acquisition agreement

OpSens has entered into a...

FEops HEARTguide LAA workflow integrated into TeraRecon software

FEops has entered int...

US FDA grants IDE approval for PROACTIVE-HF 2 study of Cordella pulmonary artery sensor

Endotronix has receiv...

Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023

Roger Malcolm Greenha...

EACTS 2023: On-X aortic valve “remains safe and effective with low dose warfarin”

Data from the On-X ao...

Elixir Medical submits approval for DynamX coronary bioadaptor in Japan

Elixir Medical has an...

Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial

Artivion has announced pr...

EACTS 2023: Statin treatment may benefit SAVR patients

Ongoing statin treatm...

Research shows “direct mechanistic link” between COVID-19 infection and heart attack, stroke

A new study has shed fres...
AI

US FDA approval for AI-powered left ejection fraction detection device

Anumana has announced US ...

MedAlliance acquired by Cordis

MedAlliance has been acqu...

US FDA grants conditional IDE approval for F2 cerebral embolic protection system

EnCompass Technologies ha...

Boston Scientific gains US FDA clearance for AVVIGO+ multi-modality guidance system

Boston Scientific has ann...

Surgeons perform historic second transplant of a genetically modified pig heart into a human

Surgeons at the Universit...

Nitrate reduces contrast-induced necropathy during coronary angiography

Inorganic nitrate reduces...

Nick West appointed to associate CMO role at Shockwave Medical

Shockwave Medical has...

David Hildick-Smith

As one of the UK’s leader...

Cardiovascular News – Issue 70 – September 2023: US Edition

In this issue: Socie...

Cardiovascular News – Issue 70 – September 2023: OUS Edition

In this issue: Socie...

Pivotal study of ShortCut leaflet splitting device completes enrolment

Pi-Cardia has announced t...

ADVERTORIAL: Hypertension guidelines “change the thinking” on renal denervation

This advertorial is spons...

European survey highlights lack of uniformity in heart team implementation

A survey of cardiac surge...

Updates to HyperVue intravascular imaging system approved by US FDA

SpectraWAVE has announced...

Enrolment complete in SAFE-MCS study of Early Bird bleed monitoring system

Saranas has completed enr...

Half of patients enrolled in SELUTION DeNovo coronary trial

MedAlliance has announced...

FastWave Medical secures multi-million dollar private financing within weeks

FastWave Medical re...

Large annulus valve launched for transseptal mitral valve replacement system

HighLife SAS has announce...

Ten-year NOTION trial data provide important insights on long-term TAVI outcomes and valve durability

Ten-year data from th...

Watchman FLX Pro gains US FDA approval

Boston Scientific has...

Enrolment begins in LOVE-DEB study of Selution SLR sirolimus-eluting balloon

The first patient has bee...

First-in-man procedure follows US FDA breakthrough designation for NyokAssist PVAD system

The first-in-man (FIM...

ESC 2023: Study assesses impact of using Heartflow FFRCT for diagnosing coronary artery disease

A study assessing the...

Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial

One-year-data from the BI...

Stroke expert J Mocco joins Protembis board

Protembis has announced t...

Radiaction Medical secures Series C2 funding and announces board addition

Radiaction Medical has ra...

UK MHRA adds capacity for medical device certification

The UK’s Medicines an...

ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events

Extended P2Y12 inhibitor ...

ESC and EACTS conclude review of left main revascularisation guidelines recommendations

A joint review of evidenc...

ESC 2023: ECLS not shown to improve survival in patients with acute MI complicated by cardiogenic shock

Early extracorporeal ...

ESC 2023: ADVENT trial shows PFA is non-inferior to thermal ablation for safety and efficacy in paroxysmal AF

Results of the first ...

ESC 2023: GE Healthcare showcases latest-generation handheld ultrasound scanner and AF tool

GE Healthcare has ann...

ESC 2023: Hot Line trials add weight to case for intravascular imaging during PCI

Data from three rando...

SCAI statement seeks to guide physician operators and facilities on renal denervation use

 The Society for Card...

ESC 2023: Siemens unveils Acuson Origin imaging platform

Siemens Healthineers has ...
FDA

SCAI: FDA panel vote “encouraging” for advance of renal denervation

The Society for Cardiovas...

Blood test may predict heart, kidney risk for those with type 2 diabetes

A simple blood test may p...

FDA panel split on risk and benefit of Symplicity Spyral renal denervation system

The US Food and Drug ...

First two US patients receive Trisol tricuspid valve

The heart teams at th...

FDA panel votes favourably on safety and efficacy of Paradise renal denervation system

The US Food and Drug Admi...

ESC 2023: Risk of MI recurrence higher in patients who do not take daily aspirin

Myocardial infarction (MI...

Elevate pLVAD completes early feasibility study

Enrolment has been comple...

Advanced NanoTherapies secures investment for development of SirPlux Duo DCB

Advanced NanoTherapie...

SCAI position statement “aims to pave the way for renal denervation in the management of hypertension”

The Society for Cardiovas...

Bryan Williams joins BHF as research leader

The British Heart Fou...

Sham-controlled trials prompt renal denervation hypertension guideline update

Latest research in th...

Forxiga granted approval from China’s NMPA for treatment of symptomatic chronic heart failure

AstraZeneca’s Forxiga (da...

First patient enrolled in global study of heart failure device trial

Heart failure start-u...

AI model may improve detection of atrial septal defect

An artificial intelligenc...

Efforts needed to improve cardiovascular research in Africa

Research published in...

STS risk calculator uses power of big data to predict cardiac surgery risk

A new digital tool la...

US FDA grants de novo approval for AI-based HCM detection algorithm

Viz.ai has received a...

STAR-T trial of DrugSorb-ATR completed

CytoSorbents has announce...

Xeltis secures additional €12.5 million from European Innovation Council

Xeltis has announced the ...

Orchestra BioMed gains FDA nod to begin study of Virtue SAB sirolimus balloon

Orchestra BioMed Holdings...

First US implants mark start of DurAVR THV early feasibility study

Anteris Technologies ...

Ilika and Cirtec Medical partner on manufacture and commercialisation of Stereax solid-state batteries

Ilika and Cirtec Medical ...
VenusP-Valve

VenusP-Valve gains FDA authorisation for transpacific clinical study

Venus Medtech has announc...

Canon Medical launches Alphenix / Evolve Edition angiography system in Europe

Canon Medical has introdu...

“Not just inventing the next stent”: The future of medtech relies on patient empowerment

Ian Meredith is a wel...
cardiovascular news top 10

Cardiovascular News’ top 10 stories of July 2023

Hitting the headlines...

CMS creates new MS-DRG codes and payments for coronary IVL

Shockwave Medical has ann...

WHO adds cardiovascular polypill to essential medicines list

The World Health Organiza...

TaurusTrio TAVI device gets first implants in aortic regurgitation clinical study

Peijia Medical has announ...

Laplace Interventional secures funding for clinical testing of transcatheter tricuspid valve technology

Laplace Interventiona...
Tria

First patients treated in Indian clinical trial of Tria surgical mitral valve

Foldax has announced ...

Transfemoral TAVI device gains US FDA breakthrough status for aortic regurgitation

Genesis MedTech has annou...

Study confirms AI detection of HFpEF using a single echocardiogram view

Applying artificial i...

Results from studies of HeartFlow coronary technologies shared at SCCT conference

Respective results fr...

First valve-in-valve procedure performed with DurAVR transcatheter valve

Anteris Technologies ...

RapidAI announces US$75 million growth investment led by Vista Credit Partners

RapidAI today announced U...

CardioPrecision moves into US market

CardioPrecision, a develo...

EACTS puts innovation to the fore

Innovation is a part ...

Michael Jaff joins board of directors at HeartBeam

HeartBeam, developer ...

Clinical trial to compare PCI and CABG in women and minorities

Researchers will carr...
Extreme temperature

Extreme temperatures and particulate pollution may increase MI mortality risk

The combination of soarin...

Global Cardiovascular Awards to recognise excellence and innovation in cardiovascular care

Entries are now open for ...

Onecrea Medical announces successful first-in-human implants of Crea aortic valve

Onecrea Medical has annou...

PECA Labs appoints new board members

PECA Labs has added Jeffr...

Latest-generation DCBs “change thinking” on treatment of coronary artery disease

 Interventional cardiol...

SCAI welcomes FDA decision to remove red flag for use of paclitaxel-coated devices in PAD

The president of the ...

Ian Meredith joins board of directors at Avertix Medical

Avertix Medical—forme...

TIMELY study will assess impact of AI platform on health of MI patients with coronary disease undergoing cardiac rehabilitation

The TIMELY consortium ann...

ESH guidelines represent a “significant milestone” for hypertension management

ReCor Medical and its...

INFINITY-SWEDEHEART trial of DynamX bioadaptor system completes enrolment

Elixir Medical has an...

Randomised trial “highly needed” to shed light on effectiveness of TAVI in bicuspid aortic stenosis patients

A dedicated, prospective ...

Patient advocacy group says ESH guideline change will improve access to renal denervation

Citizens of Europe at ris...

HOST-IDEA sub-analysis uncovers differences in ultrathin stent platforms

Results of a stent-le...

Gut bacteria linked to coronary atherosclerotic plaques

In a major Swedish st...

Timeline: Key milestones in the paclitaxel story

The release of a letter f...

Boston Scientific announces position on FDA update about use of paclitaxel-coated devices to treat PAD

Following yesterday's new...

Approval granted to commence study of renal pelvis denervation system

Verve Medical has receive...

First US patients implanted with FIRE1 remote heart failure monitoring system

FIRE1 has announced that ...

Long-awaited US FDA update finds data do not support excess mortality risk for paclitaxel-coated devices

In a letter to health...

First patient enrolled in MOJAVE study of DSR 2.0

Sequana Medical NV has an...

Alvimedica launches Kaplan curves radial portfolio for diagnostic procedures

Alvimedica has announced ...

Streamlined TAVI pathway paves the way for same-day discharge “record”

Physicians at the Jam...

Researchers develop flexible bioresorbable monitor for cardiac patients

Researchers have develope...

“World’s first” dual chamber leadless pacemaker system granted US FDA approval

Abbott has announced that...

Key messages from EBC MAIN at three years

EBC MAIN investigator...

Medtronic heralds ESH guidelines as a “turning point” for renal denervation

In the wake of the releas...
SonieVie

Combination of chronic kidney disease and diabetes associated with a higher rate of death or MI among women undergoing PCI

The combined presence of ...

Minimum level of oxygen required during cardiopulmonary bypass “may be lower than previously thought”

Researchers have found th...

Translumina acquires Blue Medical Devices

Translumina has annou...

ALL-RISE study of CathWorks FFRangio system enrols first patient

CathWorks has announc...
heart attack

Depressed ICD patients “more likely to stop medications”

Patients who feel low...

New arterial hypertension guidelines update recommendations on the use of renal denervation

New and expanded guidelin...
AI

ECG-AI algorithm for early identification of amyloidosis gains US FDA breakthrough designation

Anumana has received brea...

Vygon to manufacture vascular outflow tract for Aeson artificial heart

Vygon, a specialist in th...

Black patients nearly 50% less likely to receive revascularisation for PAD

A new study from Keck...

iTFlow blood flow analysis software gains US FDA approval

The US Food and Drug Admi...

CorWave closes series C funding round

CorWave has raised €61 mi...

egnite and JenaValve partner to assess prevalence of aortic regurgitation in USA

egnite and JenaValve Tech...
heart attack

Anxiety affects high proportion of patients with an ICD

Nearly one-third of p...

CHOP physicians conduct first-in-human implant of MASA polymeric pulmonary valve

PECA Labs has announced t...

TAVI operators should master multiple techniques to avoid coronary obstruction

In order to avoid cor...

Pacing wire for TAVI and balloon aortic valvuloplasty procedures gains US FDA clearance

Teleflex has received US ...

STEMI patients “lose years of life” due to care delays during COVID-19 lockdowns

Patients with ST-elev...

EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis

Results of the first ...
AI

US FDA approval for AI TAVI planning software

Dasi Simulations has anno...

ESC appoints Jean-François Riffaud as CEO

The European Society ...

Translumina extends European reach with Lamed acquisition

Translumina has annou...
FDA

US FDA seeks to “modernise” clinical trials with new draft guidance

The US Food and Drug ...

New study elucidates exact location of atherosclerotic plaque ruptures in carotid arteries

While the exact location ...

Research highlights “strikingly low” use of public defibrillators in cardiac arrest

Defibrillators are being ...

Lars Søndergaard joins Abbott’s structural heart business

Lars Søndergaard has left...

Conformal Medical completes series D financing round

Conformal Medical has...

First TAVI procedures performed using F2 cerebral embolic filter

EnCompass Technologies ha...

Amazon executive joins Medtronic to spearhead development in robotics and implantables

Medtronic has announced t...

First-in-man implant of “modular” TAVI device performed in Israel

Valve Medical, a wholly o...

Early discharge after TAVI: What you need to know

Discharging patients ...

ADVERTORIAL: Keeping stroke at bay for patients undergoing TAVI

This advertorial is spons...

MONITOR-HF trial results show improvement in quality of life scores for heart failure patients with CardioMEMS system

New data presented from a...

Artificial intelligence could enable life-saving early diagnosis and advance the treatment of pulmonary hypertension

Thirona recently announce...

Proprietary antioxidant complex shown to safeguard DNA from radiation exposure during aortic procedures

Cora Therapeutics has...

Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”

An international clin...

EuroPCR 2023: FAST-TAVI II highlights benefits of reducing length of stay after TAVI procedures

 Implementation of a ...

EuroPCR 2023: Pandemic cuts short EURO SHOCK trial, but results show promise for ECMO in cardiogenic shock patients 

 Enrolment in the EUR...

SCAI 2023: Similar revascularisation rates seen with ticagrelor monotherapy and DAPT in TWILIGHT trial

Ticagrelor monotherap...

HRS 2023: BIO-LIBRA study offers insights into device treatment of non-ischaemic cardiomyopathy

Preliminary results f...

HRS 2023: SOLVE-CRT results “offer new hope for patients with hard-to-treat heart failure”

Results from a pivota...

Ruggero De Paulis

Inventor of the Valsalva ...

Cardiovascular News – Issue 69 – May 2023: US Edition

In this issue: A new...

TVT registry analysis finds close to 90% success in mitral TEER procedures

A large registry stud...
AI

HRS 2023: Researchers hope to use AI to “revolutionise” prediction of sudden cardiac death

A novel artificial intell...

EuroPCR 2023: Global SYMPLICITY registry offers renal denervation insights out to three years

Analysis of the Globa...

Finding the roots of the disease before treating it: Modelling NSTEMI

Paolo Contessotto (Nation...
Bentley

Bentley launches its first product in the USA

Bentley has announced the...

SCAI 2023: No increased risk of hand dysfunction from distal compared to proximal radial artery access for cardiac procedures

A randomised controlled t...

SCAI 2023: Mechanical thrombectomy improves symptoms and quality of life in pulmonary embolism patients at six months

Six-month outcomes from F...

SCAI 2023: Two-year results “demonstrate strong clinical and haemodynamic outcomes” of Harmony transcatheter valve

Medtronic has announced t...

EuroPCR 2023: One-year BIOMAG-I results demonstrate safety and efficacy of resorbable scaffold platform

Results of the first-...

SCAI 2023: NACMI registry finds increased incidence of clotting among STEMI patients with COVID-19

Analysis from The Nor...

SCAI 2023: George Dangas begins term as SCAI president

The Society for Cardi...

EuroPCR 2023: BIOADAPTOR trial shows non-inferiority of DynamX scaffold to DES for TLF at 12 months

Elixir Medical has an...

EuroPCR 2023: Benchmark Registry data demonstrate improved TAVI efficiency

New data from the Benchma...

EuroPCR 2023: Carbon dioxide flushing prior to TAVI may offer protection against brain injury

A process of flushing...

EuroPCR 2023: Bioresorbable scaffolds as effective as drug-eluting metal stents in heart disease patients

First-generation bior...

Machine learning model provides improved cardiac risk predictions compared to “gold-standard” STS scoring

A machine learning-ba...

AATS 2023: COMMENCE aortic trial data shared through seven years

Edwards Lifesciences ...

EuroPCR 2023: Chimney stenting and BASILICA both seen to be effective in preventing TAVI-related coronary obstruction

A real-world comparis...

EuroPCR 2023: Three-year EBC MAIN results demonstrate need for pragmatism in left main bifurcation stent strategy

Operators performing ...

EuroPCR 2023: Imaging technology reduces contrast use during PCI

The use of an image-g...

Cardiovascular News – Issue 69 – May 2023: OUS Edition

In this issue: A new...

EuroPCR 2023: Robocath launches new robotic PCI platform

Robocath has announced th...

Shockwave Medical’s C2+ coronary IVL catheter launched in select markets

Shockwave Medical has ann...
Tria

Foldax acquires proprietary polymer patent family

Foldax has announced ...

SavvyWire to be assessed in COMPLETE TAVR substudy

OpSens has announced the ...

High-fat diet found to promote atherosclerosis

In a recent study, re...
heart attacks

Postmenopausal women with hardened arteries at higher risk of heart attacks than men

Postmenopausal women ...

Turning extra pulses into pluses

This educational suppleme...

More shocks for rocks

How has the new Shock...

Managing eccentric and nodular calcium with IVL

Calcified nodules are...

The r(evolution) of calcium in Bristol

Tom Johnson (Universi...
Akura Medical

Akura Medical announces successful first-in-human use of its mechanical thrombectomy platform

Akura Medical announced t...

ADVERTORIAL: Ongoing studies add to evolving understanding of TAVI valve durability

This advertorial is spons...

ADVERTORIAL: Ready for the primetime? The future role of drug-coated balloons in PCI

This advertorial is spons...

Artificial intelligence predicts cardiac pump performance

A recent study has fo...

US FDA expands indication for Farxiga

AstraZeneca’s Farxiga (da...

First patient treated in head to head trial of TAVI embolic protection devices

Emboline has announced th...

Handheld ECG device scoops CX 2023 Innovation Showcase prize

Judges of the CX 2023...

Cardiovascular News’ top 10 stories of April 2023

News highlights this ...

Vivasure Medical announces first enrolment in pivotal PATCH study

Vivasure Medical has ...

MagicTouch IDE-approved for small coronary artery disease study

The US Food and Drug Admi...

Study highlights disparity in TAVI outcomes based on availability

Research has highligh...

CX 2023: Statins save lives after aortic repair regardless of dose

Statin treatment afte...
AI

Ultromics’ AI platform for detecting cardiac amyloidosis gains FDA breakthrough status

Ultromics has been grante...

BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients

A question from Manj Gohe...

Carillon mitral contour system gains EU MDR certification

Cardiac Dimensions ha...

Cardialysis becomes independent from Erasmus University Medical Center

Cardialysis, the 40-y...

CAAS Qardia gains Japanese certification

Pie Medical Imaging has r...

Talking therapy associated with reduced risk of cardiovascular disease

Effective management of d...

Adept launches Adducted Arm Scoop product for use during image-guided procedures

Adept Medical has lau...

First US implant of Lux-Valve Plus transcatheter tricuspid valve performed in Detroit

The first transcathet...
cardiovascular disease

Increased air pollution associated with a rise in deaths from cardiovascular disease

Deaths from cardiovascula...

Shockwave Medical completes Neovasc acquisition

Shockwave Medical has...

OpSens completes European enrolment in SAFE-TAVI study

OpSens has announced the ...

Cardiovascular News’ top 10 stories of March 2023

The news agenda in March ...

AVS’s pulsatile IVL technology attracts an additional US$8.8 million to close US$28.8 million Series B round

AVS, an early-stage m...

Research project to determine how stretching and blood flow impact engineered heart valves

New research will inv...

Medtronic launches technology aimed at simplifying MRI screening for patients with implanted cardiac devices

Medtronic has announced t...

PROACTIVE-HF pivotal trial completes enrolment

Endotronix has announ...
smart watch

Smart watches could predict higher risk of heart failure and arrhythmia

Wearable devices such as ...

Smart glasses guide remote support for pioneering TAVI procedure

The UK’s first remotely-s...

Enrolment target met in ECLIPSE coronary atherectomy trial

Cardiovascular System...

Experts update consensus on left atrial appendage closure

The Society for Cardi...
remote monitoring

Abbott’s Epic Max stented tissue aortic valve gains US FDA approval

Abbott has announced ...

Azeem Latib joins Supira Medical as medical director

Supira Medical has an...

ADVERTORIAL: “No stroke is innocent”: Why stroke matters for TAVI patients

This advertorial is spons...

PADN-5 study results “exciting” for pulmonary artery denervation in heart failure and CpcPH patients

Results from the PADN...

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Saranas has announced tha...
heart attack

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

A prospective observa...
aortix

Aortix pMCS pump provides “rapid” decongestion for patients with heart failure and renal impairment

  Procyrion, ...
remote monitoring

Remote monitoring improves survival in heart failure patients analysis finds

  Abbott has ...

Thousandth patient enrolled in SELUTION DeNovo coronary study

MedAlliance has announced...

Immediate revascularisation non-inferior to staged procedure in acute coronary syndrome and multivessel disease

Immediate, complete r...

Robotic electrophysiology programme opens in south eastern USA

Stereotaxis has annou...

UK MHRA awarded £10 million to fast-track patient access to medical products

A total of £10 million ha...

Merit Medical expands SwiftNinja steerable microcatheter offering

Merit Medical has announc...

BIOMAG-I study demonstrates low rate of in-scaffold late lumen loss at six months

Angiographic and clin...

HeartBeam accquires LIVMOR assets

HeartBeam, a cardiac tech...

Vivasure Medical announces FDA IDE approval to initiate US pivotal study

Vivasure Medical has anno...

US FDA approval for Essenz heart-lung machine

LivaNova has announced th...

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Assessing myocardial ...

Cardiovascular News’ top 10 stories of February 2023

February’s trending topic...

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

A new trial of endova...

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

Edwards Lifesciences ...

EU ministers approve changes to MDR transition timetable

The European Union’s Coun...
VOYAGER

New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus aspirin following lower extremity revascularisation

Data from a new presp...

ACC 2023: Pulsed AF trial yields “promising” safety and efficacy results for PFA system

Results of the Pulsed...

ACC 2023: Equivalent recovery times shown between minimally invasive and conventional surgery for mitral valve repair

The largest randomise...

Neovasc shareholders approve acquisition by Shockwave Medical

Neovasc has announced...

ACC 2023: Intravascular imaging bests angiography guidance in trial of PCI in complex lesions

Use of intravascular imag...

ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients

Large bore mechanical...

ACC 2023: MitraClip meets endpoints at five years in COAPT trial

Final, five-year clin...

ACC 2023: Benefit of TAVI “consistent” over first three years in low risk patients

Three-year results fr...

ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial

Hotly-anticipated res...

One-year real-world data “promising” for transcatheter tricuspid repair

 One-year insights fr...

Preclinical model could aid future research of NSTEMI therapies

Researchers have detailed...
coronary artery bypass

“Urgent” action needed to improve outcomes in women undergoing coronary artery bypass surgery

Women have been found...

HyperVue intracoronary imaging system gains US FDA approval

SpectraWAVE has announced...

CRT 2023: Abbott shares new data on Navitor TAVI and Amplatzer Amulet LAAO systems

Results from the PORTICO ...

Results on ReCor Medical’s Paradise ultrasound renal denervation system published in two JAMA Network publications

ReCor Medical and its...

Five-year durability analysis of CoreValve and Evolut platforms “underscores long-term promise of TAVI”

Five-year bioprosthet...

Results of cell therapy trial in patients with heart failure due to low EF published in JACC

Results of a trial in...

CONFORMAL EFS study results presented at CRT 2023

Results from the CONF...

Risk model adds to prediction tools for surgical risk in adult congenital heart disease patients

A model designed to predi...

Medtronic welcomes ESC and EAPCI renal denervation consensus statement

Medtronic has welcomed th...
complete-revascularisation

First patient treated in A PRIORI pilot trial of Aortix circulatory support device

Procyrion has announced t...

Analysis finds clinical trials frequently overlook people with disabilities

Disabilities were underre...

Medtronic relaunches Harmony transcatheter pulmonary valve

Medtronic has announced t...

Barostim misses primary endpoint in BEAT-HF postmarket trial

CVRx has announced the pr...

US FDA clears tool to rapidly analyse RV/LV ratio

RapidAI announced it has ...

Renal denervation “can reach new shores”

The publication of a ...

Teleflex grows catheter portfolio following US FDA approval

Teleflex Incorporated has...

HOSPITAVI elucidates underlying causes of rehospitalisations among TAVI patients

 A single-centre retr...

Xeltis secures funding to progress clinical trials

Xeltis has raised €32 mil...

Important to utilise DCBs with strongest possible data behind them

NOTE: This video is ONLY ...

ACC, AHA and SCAI lay roadmap for interventional cardiology training

The American College of C...
SonieVie

ESC and EAPCI publish renal denervation consensus statement

Renal denervation represe...

TAVI pioneers discuss the past, present and future of transcatheter therapy

 As transcatheter aor...
atherosclerosis

Poor, irregular sleep linked to increased atherosclerosis in adults 45 and above

Sleeping an inconsist...

COPS trial shows feasibility of using a cutting balloon at high pressure to modify calcium prior to PCI

Attendees of the 2023 Joi...

OPN NC “super-high-pressure” coronary balloon launches in USA

SIS Medical AG has announ...

GE HealthCare to acquire AI ultrasound developer Caption Health

GE HealthCare has sig...
remote monitoring

Abbott to acquire Cardiovascular Systems

Abbott and Cardiovascular...
PCI

PCI probability seen to increase at low-volume hospitals for all populations, but has not occurred “evenly” across sociodemographic groups

A retrospective cohor...
cardiovascular news top 10

Cardiovascular News’ top 10 most popular stories of January 2023

In the opening month of 2...

ADVERTORIAL: DCB therapy offers a glimpse of interventional cardiology’s past and future

This advertorial is spons...

Home-based therapy can help to reduce anxiety and depression in cardiovascular patients

A randomised study le...

Cardiovascular News 68 – February 2023: US Edition

In this issue: Medic...

Cardiovascular News 68 – February 2023: OUS Edition

In this issue: Medic...

ADVERTORIAL: A step forward in scoring balloon catheter design

This advertorial is spons...

Automated alert tool “associated with a small decrease in contrast use” during PCI

Performance improvement c...

TruLeaf Medical to trial “two-stage” TMVR platform

TruLeaf Medical is to...

PCI can be performed as safely without on-site access to surgery, says SCAI

Percutaneous coronary int...

Cardiovascular-aortic community comes together at CX 2023

From cutting-edge aortic ...

ADVERTORIAL: A wealth of data underscore treatment choices for coronary DCBs

This advertorial is spons...

First patient treated in LeAAPS trial of left atrial appendage occlusion in cardiac surgery patients

AtriCure has announced th...
interventional cardiology trials

The interventional cardiology trials to watch in 2023

Trials in coronary im...

Slow progress made on gender balance in cardiovascular trial leadership

Little progress has been ...

Nieves Gonzalo

Interventional cardiology...

Medicare study reopens guideline debate around surgery and PCI in patients with multivessel coronary artery disease

An analysis of data f...

First US patient enrolled into study of Selution SLR coronary drug-eluting balloon

The first US patient has ...

BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system

BioVentrix, a privately h...
ultrasound device

Non-invasive wearable ultrasound sensor shown to provide mobile cardiac imaging

A group of engineers ...

Transcatheter options for AR open up TAVI to a new patient population

 Transcatheter treatm...

Hospitals without high-level designation more likely to miss strokes following TAVI procedures

A study conducted by Mich...

STS 2023: Risk assessment tool “sets a high bar” when considering alternatives to surgery in mitral valve repair

A new risk assessment...

Enrolment milestone reached in trial of angiography-based vessel fractional flow reserve in coronary revascularisation

Pie Medical Imaging has a...

Trial of super saturated oxygen therapy after PCI begins enrolment

Zoll has announced that t...

Registry data point to a declining rate of complications among primary MR patients

The largest dedicated...

Shockwave agrees to acquire Neovasc

Shockwave Medical has...

US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients

The US Food and Drug Admi...

Effects of short DAPT “consistent regardless of high bleeding risk and complex PCI”

Research evaluating the e...

Pie Medical Imaging announces launch of CAAS Qardia 2.0 echocardiography software platform

Pie Medical Imaging has l...

Viz.ai launches AI-powered Viz Vascular Suite

Viz.ai has announced ...

NICE lowers threshold for statins to prevent cardiovascular events

The UK’s National Institu...

HVR Cardio closes €10.7 million series B funding round

HVR Cardio has closed...

Depression increases likelihood of non-adherence to medical therapy post-PCI

Patients with depression ...

Multidisciplinary teams at the heart of new guidelines on aortic disease management

Closer ties between cardi...

MedAlliance’s Selution SLR receives coronary de novo IDE approval

Selution SLR, MedAlliance...

Preclinical study outlines key features of foam-based LAA closure device

A preclinical study d...

Cardiac Dimensions closes funding round to support US EMPOWER pivotal study

Cardiac Dimensions ha...

Funding secured to advance development of Pulse IVL system

AVS has announced that it...

Cardiovascular News’ top stories of 2022

Which stories, features a...

SCAI announces recipients of early career grant scheme

The Society for Cardiovas...

No sex difference seen in outcomes for transcatheter tricuspid valve intervention

Transcatheter tricusp...

ReCor appoints Lara Barghout to lead commercialisation of Paradise renal denervation system

ReCor Medical and its...

Enrolment begins in trial to assess new therapy in patients deemed unsuitable for anticoagulants

Anthos Therapeutics h...

Johnson & Johnson completes Abiomed acquisition

Johnson & Johnson has...

Machine learning enables “clinically important” characterisation of coronary artery disease

Using machine learning an...

Stem cell plasters “could revolutionise treatment of congenital heart disease”

Researchers have deve...

Enrolment begins in Impella ECP pivotal trial after US FDA green light

The first two patient...

STAR-T trial of antithrombotic removal system during cardiac surgery to continue

CytoSorbents Corporat...

First US procedure performed using ShortCut leaflet splitting device

Pi-Cardia has announced t...

Cardiology societies urge rethink of randomised controlled trial design

The current model for ran...

Pilot study of wire pacing sleeve yields positive results in TAVI and PCI procedures

A first-in-human trial us...

Corindus rebrands to Siemens Healthineers Endovascular Robotics

Corindus has been reb...

Improved follow-up care needed for Black patients post-PCI to prevent hospital readmission and death

In a recent study whi...

EU Commission to propose delay to MDR implementation

Europe’s health commi...

UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction

AstraZeneca has today ann...

TRICares secures financing to fund development of Topaz tricuspid valve replacement system

TRiCares has announce the...

First patient randomised in RESPONDER-HF trial of Corvia atrial shunt

Corvia Medical has an...

Study finds PET technology more effective to determining need for coronary stents bypass surgery

A new method for dete...

ESC warns of cardiac device shortage due to implementation of MDR regulations in Europe

The European Society of C...

Postmarket data point to lower rates of PVL with Acurate neo2 TAVI valve

The addition of an an...
Stephan Windecker (left) presents one-year outcomes from the TRISCEND study

TRISCEND trial reports one-year outcomes in patients undergoing transcatheter tricuspid valve implantation

One-year results from...

ADVERTORIAL: TAVI valve durability and reliability: How patient lifetime management is evolving

This advertorial is s...

Swiss parliament votes to accept US FDA-approved medical devices

The Swiss Federal Assembl...

Otsuka Medical Devices and ReCor Medical submit pre-market approval of Paradise ultrasound renal denervation system

  Otsuka Medi...

DurAVR heart valve system gets green light from US FDA for early feasibility study

Anteris Technologies has ...

First implant of MonarQ tricuspid valve replacement system performed in Copenhagen

inQB8 Medical Technol...

Nyra Medical secures investment for transcatheter mitral valve repair technology

Nyra Medical has anno...

First-in-human procedure performed using Impella RP Flex

The first implant procedu...

Ninety-day readmission and mortality found to be higher among Black patients following PCI

A retrospective analysis ...

Late-breaking Xlimit randomised trial data shared at CSC 2022 congress

Data presented at an inno...

Timothy D Henry

A pioneer of one of the f...

Carmat resumes commercial implants of Aeson artificial heart

Carmat has announced the ...

CroíValve reports successful first in human implants of its Duo tricuspid coaptation valve system

CroíValve has announc...

Cardiovascular News 67 – November 2022: OUS Edition

In this issue: Lates...

Cardiovascular News 67 – November 2022: US Edition

In this issue: Lates...

Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND

Extended follow-up of...
viz series d

AI system to aid decision making for aortic aneurysm treatment

Viz.ai has announced a pa...

BRIGHT-4 trial: Bivalirudin cuts 30-day mortality for STEMI patients undergoing PCI compared to heparin

Bivalirudin is a safer an...

Soundbite Medical enters into a license agreement with VFLO Medical to bring its products to Chinese region

Soundbite Medical Soluti...

CVRx launches new version of neuromodulation device intended to treat heart failure

CVRx—the developer of the...

Siemens Healthineers to demonstrate remote capabilities of Corindus CorPath GRX robotic system using Mentice VIST simulator

Mentice has announced tha...

Use of clinical support platform “reduces risk of kidney injury” from PCI

Patients at high risk for...

RELIEF clinical study to assess use of Cardioform septal occluder for migraine relief

WL Gore & Associa...

Neovasc Reducer assigned outpatient reimbursement code from CMS

Neovasc has announced tha...

ReCor Medical announces consistent reduction of blood pressure in pooled analysis of three clinical trials at AHA 2022

ReCor Medical and its...

AHA 2022: SPYRAL HTN-ON MED study demonstrates “meaningful clinical benefits” consistent with other renal denervation trials

Medtronic has announc...

AHA 2022: First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients with high-quality great saphenous vein

The first results fro...

New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines

The American College of C...

Johnson & Johnson reaches agreement to acquire Abiomed

Johnson & Johnson is ...

Impella RP Flex with SmartAssist receives US FDA approval to treat right heart failure

Abiomed has announced tha...

Transit Scientific announces US FDA clearance for XO RX angioplasty platform

Transit Scientific has an...

CX Aortic Vienna witnesses techniques “at the edge of endovascular intervention”

The application of ne...

CX Aortic Vienna provides timely reminder that rushing the patient to the operating room is “not always the answer”

This session really reminds clinicians that the answer is not always an intervention in 100% of patients.

Aortic advances: New techniques and technologies in the spotlight

Heinz Jakob (Essen, G...

Carmat gains approval to resume clinical study of total artificial heart

Carmat, developer of ...

US FDA accepts post-approval study reports for Impella

Abiomed has announced...

First patients treated in SAFE-TAVI clinical study

OpSens Medical has announ...

Bruce Ovbiagele named editor-in-chief of the Journal of the American Heart Association

Bruce Ovbiagele, asso...

Selution SLR receives US FDA investigational device exemption approval for coronary clinical trial

Selution SLR, MedAlliance...

Ticagrelor after CABG associated with a decreased risk of vein graft failure compared to aspirin

In patients undergoin...

LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke

Researchers are to in...

AccurKardia and Mawi link up to add automated ECG analytics for the new Mawi Watch

AccurKardia, a software c...

HeartFlow receives US FDA approval for Plaque and RoadMap analysis AI products

HeartFlow has receive...

MedAlliance to be acquired by Cordis

MedAlliance is to be acqu...

Rates of stroke and embolism lower with apixaban compared to rivaroxaban

In a large, population-ba...

Abiomed gains FDA approval for Impella low profile sheath

The US Food and Drug ...

Swedish registry data point to survival benefit for younger patients undergoing CABG

An analysis of data f...

Analysis shows survival benefit in high-risk PCI supported by Impella

An analysis of more t...

Swedish and Dutch organisations agree to research collaboration

The Uppsala Clinical ...

Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award

The developers of a c...

CathWorks gains Japanese regulatory approval for FFRangio system

CathWorks has announc...

EACTS 2022: Global studies will fill gap for “high-quality evidence” on invasive treatment of ischaemic cardiomyopathy

A global research ini...
PCI

Mortality drops for acute type A aortic dissection, still high for patients not receiving surgery

  The chance of a...

EACTS 2022: “Wake up call” for trialists over gender balance

Clinical trials in ca...

Latest data underscore optimism for future of renal denervation

Ajay Kirtane (Columbi...
flash

FLASH results demonstrate “excellent safety profile” of the FlowTriever system in full US cohort

Results of the FLASH ...

Long-term P2Y12 monotherapy after PCI “may be a promising strategy”

Three-year outcomes from ...

Enrolment completed in trial comparing PCI in diabetic patients

ABILITY DIABETES-GLOBAL, ...

Puzzle Medical wins 2022 TCT Shark Tank innovation competition

Puzzle Medical Devices wa...

Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures

The use of rivaroxaba...

Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients

Results of a new per-...

First US TAVI procedure performed using SavvyWire guidewire

OpSens has announced that...

Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022

Biotronik has announc...

FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI

Medtronic has received Fo...

Clinical trial of TAVI in severe aortic regurgitation completes enrolment

JenaValve Technology has ...

TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation

Analysis of data from...

TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures

Results from a multic...

Medtronic expands US rollout of Evolut FX TAVI system

Medtronic has announced t...

Shockwave initiates all female coronary IVL registry study

Shockwave Medical has ini...

Breakthrough device designation granted for SirPlux Duo coronary DCB in small vessels

Advanced NanoTherapie...

TCT 2022: Amulet occluder keeps pace with Watchman at three years

Long-term follow-up o...

TCT 2022 hears “important data” from renal denervation trials

Findings from the RAD...

TCT 2022: Valentin Fuster receives career achievement award

The major contributio...

TCT 2022: Pascal non-inferior to MitraClip in head-to-head trial in degenerative MR patients

The first randomised ...

TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection device in PROTECTED TAVR

Among patients underg...

US FDA grants 510(k) clearance for SavvyWire TAVI guidewire

OpSens has received 510(k...

Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser

The 2022 Transcathete...

Abiomed given green light for RECOVER IV randomised trial

Abiomed has announced two...

Edwards’ Pascal Precision transcatheter valve repair system receives FDA approval for degenerative mitral regurgitation

Edwards Lifesciences has ...

Key learnings from Manta device study to be presented at TCT

Teleflex has announced th...

Cardiac Implants announces successful adjustment procedure using its Tri-Ring device to treat TR

Cardiac Implants has anno...

Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB

Concept Medical has a...

TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude

A budget impact analy...

Vascade vascular and venous closure devices gain CE mark

Haemonetics Corporati...

Latest Sapien TAVI valve features anti-calcification technology

Edwards Lifesciences has ...

Three-year data “reinforce safety and efficacy” of Abbott’s Amplatzer Piccolo in infants with PDA

Abbott has announced thre...

The time for change is now: Call for action over “ageing and unbalanced” cardiothoracic surgery community

Analysis of the global ma...

Results of cuffless blood pressure monitor presented at AHA Hypertension Sessions

Results of an analysis of...

First patient joins study of SSO2 therapy post-PCI

Zoll Medical has announce...

Abbott’s Amplatzer Talisman PFO occlusion system launched in Europe

Abbott has announced the ...

AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal AF

AtriAN Medical has announ...

Tom Nguyen

As a proponent of minimal...

Cardiovascular News’ top 10 most popular stories of August 2022

The most read stories fro...

FDA clears Viz.ai’s right-to-left ventricle ratio algorithm

Viz.ai has received US Fo...

Latest centre begins using Philips’ Verisight Pro 3D intracardiac echocardiography catheter

Royal Philips has announc...

New DAPT labelling approved for Watchman FLX device

Boston Scientific has...

Why ClotTriever is a “gamechanger” for the treatment of deep vein thrombosis

 Andrew Wigham (Oxfor...

First patient enrolled in Hyper II study evaluating hybrid approach in long diffuse CAD

Cardionovum has annou...

JenaValve raises US$100 Million to advance Trilogy TAVI system

JenaValve Technology has ...

ESC 2022: Risk score predicts mortality for AF patients after TAVI

Researchers have deve...

ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD

Abbott has announced ...

ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures

Transradial access fo...

ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI

Fifteen-month results...

ESC 2022: Kidney disease patients with coronary disease see no improvement in survival at five years with an invasive approach

In patients with adva...

ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI

Selection of non-infa...

ESC 2022: High-risk aortic stenosis could be picked up using AI

Late-breaking researc...

ESC 2022: POST-PCI trial finds no benefit to routine functional testing in high-risk PCI patients

Among high-risk patie...

ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT

Results of one of the...

ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction

Percutaneous coronary...

ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care

Use of a ‘polypill’ a...

ŌNŌCOR reports first-in-human use of ŌNŌ system for removal of atrial blood clot

ŌNŌCOR has announced in a...

ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes

The timing of dosing ...

Programme released for TCT MedTech Innovation Forum

The Cardiovascular Re...

Medtronic launches Onyx Frontier coronary stent following CE mark approval

Medtronic has announced t...

Cardiovascular News 66 – August 2022: OUS Edition

In this issue: Call ...

Cardiovascular News 66 – August 2022: US Edition

In this issue: Call ...

Miracor’s PiCSO technology approved by FDA for investigational device exemption study

Miracor Medical has a...

First-in-human procedure completed using ShortCut Mitral device

Pi-Cardia has announced a...

Edwards gains CE mark for Pascal Precision system for mitral and tricuspid regurgitation

Edwards Lifesciences ...

Restore EF study “shows heart function, symptom improvements” for high-risk PCI patients supported by Impella

Abiomed  has announced th...
CX Aortic Vienna

CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care

CX Aortic Vienna returns ...

AHA and CRF announce collaborative education programme

The American Heart Associ...

Spotlight turns to TAVI in patients with moderate aortic stenosis

Ongoing clinical tria...

Cardiovascular News’ top 10 most popular stories of July 2022

The most read stories fro...

“Worrisome” rise in cardiovascular disease predicted out to 2060

Projected rates of cardio...

“Positive” 30-day outcomes for patients receiving Optimum transcatheter aortic valve

Thubrikar Aortic Valve ha...

Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine

Cardiac surgeons from Nor...

Genetic “cure” for cardiomyopathy is selected as winner of Big Beat Challenge

A project to develop ...

Three-year results of RANGO registry presented at EuroPCR

iVascular has announced t...

Neovasc gains approval for protocol supplement to COSIRA-II trial

Neovasc has announced...

Digital drainage system for cardiac surgery “safe and effective”

Centese has announced the...

Pi-Cardia gains FDA nod for study of ShortCut leaflet splitting device

Pi-Cardia has received In...

Ultrasound renal denervation meets primary efficacy endpoint in RADIANCE II study

ReCor Medical and Otsuka ...

Steps needed to include disadvantaged patients in mitral and tricuspid trials

Incentives for the en...

Cathbot completes enrolment in clinical study of robotic-assisted PCI in China

Cathbot—a joint venture b...

Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI

Preventing coronary o...

New funding for research to examine use of blood pressure cuffs for heart failure patients with pacemakers

A research project at...

FDA grants breakthrough status for Accucinch ventricular restoration system

Ancora Heart has anno...

First patients enrolled in study of Booster spiral balloon therapy for acute myocardial infarction

Intratech Medical has ann...
VenusP-Valve

VenusP-Valve gains approval from China’s NMPA

The VenusP-Valve (Ven...

Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition

Medtronic today announced...

Stress testing can guide patient selection for coronary revascularisation

Patients identified b...

TAVI will continue to grow, says pioneer of the procedure

 Transcatheter aortic...

Echocardiographers face “under-recognised” radiation exposure risk in the cath lab

Echocardiographers may be...

TCT MedTech Innovation Forum to spotlight opportunities for innovation

The Cardiovascular Resear...

Analysis shows “positive trend” with thinner strut stents in patients with small vessels

A subgroup analysis o...

HeartBeam expands software platform to cover unstable angina

HeartBeam is expanding th...

Cardiovascular News’ top 10 most popular news stories of June 2022

The most read stories fro...

Female representation in interventional cardiology remains low, but there is cause for hope

Suzanne Baron and Ki ...

Advanced NanoTherapies closes Series A funding round

Advanced NanoTherapie...

EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients

Results from the firs...

First patients enrolled in Manta Ultra vascular closure device study

Teleflex has announce...

AF after surgery is linked to an increased risk of heart failure hospitalisation

People who develop an arr...

Acutus launches expanded suite of left-heart access products

Acutus Medical has an...

CABG “associated with favourable outcomes and increased long-term survival” among octogenarians

A retrospective study fro...
SonieVie

SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology

SoniVie recently announce...

CONFORM pivotal trial of CLAAS system begins enrolment

Conformal Medical has...
heart attack

NICE recommends new treatment to reduce stroke and heart attack deaths

The National Institut...

TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens

Dual antiplatelet the...

TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device

Transcatheter aortic ...

TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria

Analysis of the EXPAN...

TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”

Data from the first r...

First patient treated in HEAL-IST clinical trial

AtriCure has announced th...

AI holds “huge potential” for cardiology

The potential to utilis...
adept medical advertorial

ADVERTORIAL: Advancing radial ergonomics

This advertorial is spons...

Patients with mitral annulus calcification at higher risk of mitral valve dysfunction

A retrospective review of...

First-in-human results of Captis embolic protection device presented at EuroPCR 2022

Filterlex Medical has...

Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care

A study has revealed the ...

New consensus statement will take into account latest clinical trial evidence on renal denervation

 A new consensus stat...

EuroPCR 2022: “Clear need” for transcatheter options for tricuspid regurgitation

 “At the moment, tric...

UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year

Transcatheter aortic ...

EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies

The use of distal rad...

AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure

Concurrent tricuspid ...

EuroPCR 2022: Robotic PCI changes the cath lab environment

 Robotic-assisted per...

SCAI 2022: Analysis looks at coronary IVL outcomes in women and men

New data confirming o...

SCAI names Sunil Rao as incoming president

Sunil Rao (Duke Unive...

Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial

Endotronix has announ...

Shockwave Medical and Genesis MedTech obtain regulatory approval in China for intravascular lithotripsy

Shockwave Medical and Gen...

Adept announces Prone Support product launch

Adept Medical says it...

EuroPCR 2022: CLASP TR among the trials to watch in the tricuspid space

 Transcatheter tricus...

EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study

One-year outcomes of the ...

EuroPCR 2022: Lifetime management is an important question for the evolution of TAVI

 Matti Adam (Cologne,...

EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique

Use of the cusp overl...

EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety

Results of the 20-patient...

EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed

Patients in England w...

EuroPCR 2022: Sham controlled trials have “revitalised” interest in renal denervation

 “Renal denervation h...

SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”

Analysis of data from a U...

Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022

Biotronik has shared ...

EuroPCR 2022 hears new data on robotic PCI

New data on robotic-assis...

Vivasure Medical announces Series D financing to advance portfolio of PerQseal vessel closure devices

Vivasure Medical has anno...

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity

Analysis of the MASTER DA...

EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension

Late-breaking trial d...

Medtronic gains FDA approval for Onyx Frontier drug-eluting stent

Medtronic has announced t...

Cardiovascular News 65 – May 2022: US Edition

In this issue: New d...

Cardiovascular News 65 – May 2022: OUS Edition

In this issue: New d...

Analysis charts “significant” growth of US TEER procedures since 2012

A US analysis comparing t...

Abbott funds programme to boost diversity in clinical trial leadership

Abbott has announced a ne...

Vijay Kunadian

Vijay Kunadian (Newcastle...

ADVERTORIAL: Cath lab technologies for medicine in the precision age

This advertorial is spons...

ADVERTORIAL: TAVI valve durability under the microscope

This advertorial is s...

Cardiovascular News’ top 10 most popular stories of April 2022

The most read stories fro...

Artificial intelligence could make endovascular aortic repair outcomes more predictable

At the 2022 Charing C...

DCB in PCI: Adjunctive therapy or standard of care?

This educational suppleme...

“TAVI was my baby, now it is a teenager”

In the history of transca...

Health Canada approval granted for SavvyWire TAVI guidewire

OpSens has announced that...

Japanese and US regulatory approvals granted for BioFreedom stent

Biosensors Internatio...

First patient enrolled in EXPAND TAVR II trial

Medtronic has announc...

Medtronic names Laura Mauri as new chief scientific, medical and regulatory officer

Medtronic has announced t...

SCAI issues position paper on transaxillary arterial access

The Society for Cardiovas...

Translumina announces launch of dual drug polymer-free coated stent

Translumina has announced...

“Hybrid” model likely to be a hallmark of the post-pandemic era for heart failure care

The pandemic saw a bo...

Corindus relocates Massachusetts headquarters to accommodate company growth

Corindus, a Siemens Healt...

FDA approves coronary use of XO Cross support catheter system

Transit Scientific ha...

Quest International and CathWorks partner to scale up FFRangio

Quest International a...
viz series d

Viz.ai raises US$100 million in Series D funding to expand AI technologies

Viz.ai has raised a US$10...
VenusP-Valve

VenusP-Valve gains CE mark

Venus Medtech's trans...

CeloNova to seek medical device partnerships

CeloNova BioSciences ...

ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT

Patients treated with...

Cardiovascular News’ top 10 most popular stories of March 2022

The most read stories fro...

FEops Heartguide receives FDA clearance for LAAO planning capabilities

FEops has announced t...

First patient in Japan treated with Impella 5.5 with SmartAssist

Abiomed has announced...

First patient enrolled in BIOMICS study for CTO-PCI

Biosensors International ...

ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years

Patients who received a t...

ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19

Latest results from t...

ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis

A head-to-head comparison...

ACC.22: Three-year data show “durable blood pressure reductions” through renal denervation

Long-term data from the f...

ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial

Patients with tricuspid r...

Corvia announces publication of REDUCE LAP-HF II data

Corvia Medical has an...

ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery

Percutaneous coronary...

SafeCross transseptal balloon gets first commercial use

East End Medical has ...

Philips launches Ultrasound Workspace at ACC.22

Royal Philips is launchin...

SCAI aims to minimise risks in medical proctoring of new techniques and technologies

The Society for Cardiovas...

FDA approval granted for Mitris Resilia mitral valve replacement

Edwards Lifesciences has ...

Shockwave coronary IVL gains Japanese approval

Shockwave Medical’s C2 co...

First patient enrolled in PICSO-AMI-V study

Miracor Medical has a...

RADIANCE-II renal denervation trial completes enrolment

Investigators have comple...

Carmat sets date for resumption of implants of artificial heart system

Carmat, designer and ...

Deep learning tool could predict future myocardial infarction

Researchers have deta...

First-in-human study paves way for further clinical trials of Valvosoft

Cardiawave has announced ...

Expert group sets out principles for device-led hypertension trials

A consensus document outl...

Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system

Four radial cases usi...

Venus Medtech targets European growth with senior appointment

Venus Medtech has appoint...
Woman patient

Women less likely to receive cardiogenic shock treatment

Women are less likely to ...

Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients

Only 76% of heart attack ...

Putting “stent regret” behind us

Nick West, chief medi...

Xeltis announces “promising outcomes” in restorative graft trials following EU financing

Xeltis has announced prom...

ACC issues clinical guidance on cardiovascular consequences of COVID-19

The American College of C...

CSI’s Propel pVAD system gets first-in-human use

Cardiovascular Systems—CS...

First patient treated in study of PerQseal+ vessel closure device

Vivasure Medical has ...

Remote blood pressure monitoring beneficial for stroke survivors in under-resourced areas

A new strategy using ...

Cardiologists without borders

“When I was one year ...

Ryan Egeland joins Big Sky Biomedical

Big Sky Biomedical ha...

Medtronic expands reach of AI-powered surgical video management and analytics platform

Medtronic has announc...

Cardiovascular News’ top 10 most popular stories of February 2022

The most read stories fro...

CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI

Two-year findings fro...

CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition

A novel transcatheter...

CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT

Final findings from t...

CRT 2022: Four-year LRT data “support TAVI in low-risk patients”

Four-year data from t...

VISION study concludes troponin is a benchmark for cardiac surgery risk

Levels of high-sensitivit...

Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed

Biotronik has announc...

CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX

Results from a new an...

Women underrepresented in cardiovascular clinical trial leadership positions

Women remain underrep...
Tria

CRT 2022 hears results of animal study of Tria TAVI valve

Results from the firs...

CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years

Final five-year resul...

CX returns to in-person format once more in the London spring

Charing Cross (CX) chair ...

Partnership to promote wearable tech in cardiology trials

Wearable technology and d...

High coronary artery calcium score increases risk of heart attack or stroke

Patients with both a ...

CX 2022 returns to in-person format facing challenges and opportunities in the aortic field

Anticipation is build...

Teleflex catheters and coronary guidewires cleared for CTO PCI

Teleflex has announced th...

New data underpin drive towards earlier AF ablation strategies

Historically, cathete...

Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality

Valve-in-valve transc...

Siemens introduces “integrated” cath lab imaging system, Artis icono biplane

Siemens Healthineers has ...

Ross procedure “associated with better long-term outcomes” for aortic valve replacement

The “Ross procedure” ...

Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure

Abbott has announced that...

On-pump and off-pump CABG confer similar outcomes over 10 years

A 10-year study monitorin...

Heart team approach points to mortality benefit in complex cardiac patients

Consultation by a heart t...

New technique outperforms manual assessment of thoracic aortic aneurysm growth

Researchers have develope...

Robert Califf to return as US FDA commissioner

Cardiologist and rese...

Expanded robotic training will benefit cardiovascular care

Robotic systems have the ...

3D printing to support physician training and coronary device testing

The donation of new 3...

Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

Elixir Medical has an...

Boston Scientific closes acquisition of Baylis Medical Company

Boston Scientific has...

MedHub announces investment and pivotal study completion

MedHub has announced the ...

Supreme drug-eluting stent “safe and effective” in complex coronary lesions

The Supreme healing-t...

Portsmouth Hospital: How tech is guiding decision-making in the cath lab

Peter Haworth (Portsmouth...

HeartFlow and Longview terminate merger agreement

HeartFlow has announced t...

Lung cancer patients with higher level of coronary calcium at increased risk for adverse cardiovascular events

Lung cancer patients with...

IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation

The use of intravascular ...
cardiovascular news top 10

Cardiovascular News’ top 10 most popular stories of January 2022

The most read stories fro...

Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool

Acarix has submitted a br...

“Game changing” photon-counting CT system arrives at John Radcliffe Hospital

The John Radcliffe Ho...

Philips expands haemodynamic assessment in its Lumify handheld ultrasound system

Royal Philips has announc...

Second phase of ASCENT ASD trial begins

Atheart Medical has a...

Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial

The placement of an i...

First patient enrolled in RISE SC study of coronary balloon

Biosensors has announced ...

Breakthrough designation granted to CardiaAMP cell therapy system for heart failure treatment

BioCardia has announced t...

CroíValve completes funding round for study of Duo system

CroíValve has raised ...

Death due to cardiovascular disease more likely among Black adults born in the USA

Black adults born in ...

SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation

The Society for Cardi...

Abbott’s Nick West points to future role of AI in the cath lab

Abbott has released a...

ADVERTORIAL: Fresh data paint a positive picture for IVL in both eccentric and nodular coronary calcium

This advertorial is spons...

ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases

This advertorial is spons...

Susheel Kodali

Born in India and rai...

Cardiovascular News 64 – February 2022: US Edition

In this issue:  Coro...

Cardiovascular News 64 – February 2022: OUS Edition

In this issue:  Coro...

STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery

Insights from what wa...

PROACT clinical trial results published for On-X mechanical mitral valve

Artivion has announced th...

SCAI issues updated expert consensus statement on cardiogenic shock

The Society for Cardi...

STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president

Cardiothoracic surgeo...

STS 2022: Socioeconomic status may impact outcomes after mitral valve surgery

Patients with mitral ...

InnovHeart completes funding round to advance Saturn TMVR system

InnovHeart, developer of ...

JIM 2022 moves to June slot

Organisers of the Joint I...

First patient enrolled in TRANSFORM II study of sirolimus-coated balloon

The first patient has...

“Considerable” reduction in PCI-related radiation reported in last decade

Radiation exposure during...

Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn

Researchers have warned t...

FDA issues two final guidances for including patient perspectives in medical device studies

The US Food and Drug Admi...

Grant funding for 3D-printed paediatric heart models

Congenita has been named ...

Study suggests a more proximal landing zone is preferred for TEVAR of acute type B aortic dissections

A review evaluating t...

Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection

New clinical practice gui...

New publication “extends evidence for clinical benefit” with CytoSorbents’ haemoadsorption technology into type A dissection aortic surgery

CytoSorbents has called a...

Scoreflex NC PTCA catheter gains FDA premarket approval

Cardiovascular Systems (C...

Gore’s Cardioform Septal Occluder reaches 10-year milestone

WL Gore & Associa...

Young surgeons to benefit from Transatlantic grant scheme

In a joint programme ...

Prolonged TV watching may increase risk of venous thromboembolism

A new study reports that ...

Philips integrates cloud-based AI and 3D mapping into its mobile C-arm system series

Royal Philips today a...
Timir K Paul

Downgraded guideline recommendations on embolic protection during saphenous vein graft intervention are a step in the right direction   

New guidelines from the A...
IVL

Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases

Cardiovascular Systems re...

TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients

A propensity score-matche...

Pioneering pig to human heart transplant heralded as a breakthrough

A 57-year-old patient wit...

AATS and STS opt not to endorse joint coronary revascularisation guidelines

The American Association ...

Omicron surge sees STS move 2022 annual meeting online

The Society of Thoracic S...

Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines

Terumo Medical Corporatio...

Robocath completes European study of robot-assisted PCI

Robocath has announced th...

Impella gains a trio of regulatory approvals

Regulators in three count...

Evolut PRO TAVI valve gains approval in China

Medtronic has announc...
cardiovascular news top 10

Cardiovascular News’ top 10 most popular stories of December 2021

The most read stories fro...

First patient enrolled in COSIRA-II trial of Neovasc Reducer

Neovasc has announced enr...

Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change

Endotronix has announ...

Partnership to develop training system for complex valve-in-valve procedures

Biomodex and the Mont...
Vesalio

Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI

Vesalio recently announce...

FDA clears CavaClear IVC filter removal laser sheath

Royal Philips has ann...
Tria

First clinical results for Tria biopolymer valve published

Foldax has announced ...
Sapien 3

Sapien 3 with Alterra prestent gains FDA approval

Edwards Lifesciences ...

US physicians “among nation’s first” to implant neurostimulator technology for advanced heart failure

Doctors at St David's Med...

Research suggests many patients may be safely discharged without opioids after cardiac surgery

Many patients undergoing ...

EMPAKT CHF trial points to change in assessment acute heart failure patients

FAST BioMedical has annou...

Initial implants of Thubrikar TAVI system to commence

Thubrikar Aortic Valve ha...

AI improves confidence in CAD detection from a stress echocardiogram

Ultromics has announc...

HeartFlow submits premarket application for coronary plaque assessment

HeartFlow has announced i...

“Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI

Results of the CHEETA...

Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX

Svelte Medical Systems ha...

Opsens files 510(k) submission to US FDA for TAVI guidewire

Opsens has filed a 510(k)...

Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery

The Society of Thoracic S...

Machine learning predicts 10-year risk of death in patients with suspected or known coronary artery disease 

The likelihood of patient...

Understanding the risk of acute kidney injury in the cath lab

Huge strides have bee...

Heart team approach central to updated coronary revascularisation guidelines

New guidelines for corona...

Machine learning may help identify people at risk of thoracic aortic aneurysm

A team led by investigato...

Coronary artery modelling technology enables 3D reconstruction of coronary vasculature

RSIP Vision has announced...

Philips expands cardiac ultrasound portfolio

Royal Philips has ann...
Tria

Foldax commences clinical study of Tria surgical aortic valve in India

Foldax has announced that...

Venus Medtech announces Cardiovalve acquisition

Venus Medtech has announc...

SyMap Medical closes US$100 million financing round

SyMap Medical has ann...

Restore Medical announces preliminary results from first-in-human use of ContraBand

Restore Medical has annou...

“Encouraging” early results for TEER seen in bRIGHT registry

 The first analy...

Survey: Bullying “commonly experienced” by UK cardiology trainees

One in 10 junior doctors ...

Interim REVERSE-IT trial results published in NEJM Evidence

Interim results from ...
cardiovascular news top 10

Cardiovascular News’ top 10 most popular stories of November 2021

Featuring stories from th...
AI

AI-based algorithm could predict outcomes after cardiac surgery

A novel artificial intell...

Soundbite Medical gains fifth US patent for its plaque modification technology

Soundbite Medical Solutio...

Robocath announces completion of first robotic coronary angioplasty with R-One in China

Robocath has announced th...

TMVI is a “reproducible and reliable” tool for eliminating mitral regurgitation

Findings of the CHOIC...
TAVI

PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials

Findings from an on-t...

Mirvat Alasnag

Mirvat Alasnag is the Gul...

CSI recalls Wirion embolic protection device

Cardiovascular Systems ha...

PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion

Two-year findings of ...

PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation

First clinical result...

PCR London Valves hears first results from NeoChord Nexus mitral repair device

The first 30-day resu...

First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire

Opsens has announced the ...

Research reveals improved outcomes and decreased mortality in management of aortic dissections with care plans designed by multidisciplinary expertise

The Minneapolis Heart Ins...

First patients enrolled in FAST III study of vFFR-guided PCI

The first patients have b...

ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease

European Society of Cardi...

SCAI pushes revised standardised language to improve cardiogenic shock care

New guidance on the d...

Findings of meta-analysis “move the conversation forward” on left main revascularisation

A meta-analysis compa...

Nonagenarians should not be denied TAVI based solely upon age

Nonagenarians should not ...

AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI

An updated risk score...

AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG

Use of a novel, venou...

HeartVista receives FDA clearance for use of its AI software on Siemens MRI scanners

HeartVista has received U...

AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation

Coronary artery bypass gr...

AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery

Asymptomatic patients wit...

What to expect from AHA 2021

Ahead of the American Hea...

ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab

This advertorial is spons...

“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021

Early data presented ...

Caption Health and Ultromics partner to increase availability of heart disease detection and management tools 

Caption Health and Ultrom...

Abbott research highlights opportunities for improvements in diagnosis and treatment of cardiovascular disease

Abbott has released new r...

Ron Waksman joins SIS Medical AG advisory board

SIS Medical AG has ap...

Lessons from SURTAVI

Transcatheter aortic valv...

Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB

Cardiovascular Systems ha...

Patients more likely to survive a cardiac arrest in the operating room than the cath lab

Patients who went into ca...

Two-year results of mitral valve repair using ChordArt device published

CoreMedic has announced t...

Medtronic announces 2045 net zero emissions ambition to combat climate change

Medtronic has announced i...

TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold

Data from the BIOSOLV...

TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve

Six-month results fro...

TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system

Early data for the se...

TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device

Findings of the SWISS...

TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens

Patients receiving an...

TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella

The final results of ...

TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up

Left atrial appendage...

TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke

Five-year clinical an...

TCT 2021: CHOICE-CLOSURE finds higher rate of access-related vascular complications in plug-based closure strategy post-TAVI

Results from the larg...

TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds

An economic analysis ...

TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart

Penumbra has announce...

TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting

One-year outcomes from th...

TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents

Results from SUGAR, a ran...

TCT 2021: Randomised trials show “consistent” reduction in blood pressure through renal denervation

Randomised placebo-contro...

TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation

Six-month outcomes fr...

TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial

Lesion selection for perc...

TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease

Percutaneous coronary...

TCT 2021: Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study

Medtronic has announced f...

Cardiovascular News 63 – November 2021: US Edition

In this issue:  MAST...

Cardiovascular News 63 – November 2021: OUS Edition

In this issue:  MAST...

TCT 2021: Philips to showcase developments in its interventional portfolio

Royal Philips has preview...
Aortix

Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021

Procyrion has announced t...

Aktiia announces Series A funding round

Hypertension health-t...

ReValve Solutions announces first use of its Palmetto mitral valve replacement system

ReValve Solutions has ann...

TCT 2021: Studies to highlight patient outcomes with Impella

Results from two studies ...

Bifurcation lesions: Exploring the latest science

This educational suppleme...

AHA and ACC release clinical guidelines for evaluation of chest pain

Joint clinical practice g...

EACTS speakers question evidence underpinning guidelines for left main revascularisation

Speakers at the European ...

Longest available real-world follow-up data for Tendyne valve support use of device in select patients

The longest avail...

Enrolment completed in study of Teleflex QuikClot device

Teleflex announced the co...

Research finds poor level of surveillance following aortic dissection repair

Patients who survive ...

CRF waives cost for digital access to TCT 2021

The Cardiovascular Resear...

PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent

Sinomed has announced...

Cardiac CTA parameters predict post-TAVI mortality

Cardiac CT angiograph...

First European implants of Trilogy TAVI system completed

JenaValve Technology has ...

Heartflow announces start of REVEALPLAQUE clinical trial

HeartFlow has announced t...

Study charts “inequities” in growth of TAVI in US hospitals

The expansion of transcat...

Ethnic and racial minority cardiologists face professional discrimination and exclusion

Ethnic and racial minorit...

Type A dissection enters a new revolution

“We are at the beginn...

EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials

The underrepresentati...

Clinical study of SavvyWire TAVI guidewire commences

OpSens has announced the ...

Next generation of aortic surgeons need open and endovascular skills

Building and maintain...

ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases

ReCor Medical has announc...

Baylis Medical Company to sell its cardiology business to Boston Scientific

Baylis Medical Company ha...

New technologies will simplify and shorten aortic surgical procedures while reducing radiation

In a session on “Redu...

Philips’ Bert van Meurs discusses the future of imaging in the cath lab

Bert van Meurs is the chi...

Patients should get a choice between open and endovascular surgery for aortic conditions, CX audience agrees

A decisive vote at CX...

Open surgery remains a well-accepted as option to treat challenging aortic arch

Results of a poll con...

VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions

A worldwide committee...

NeoChord announces completion of first-in-human case with NeXus TMVr technology

NeoChord has announced su...
cardiovascular news top 10

Cardiovascular News’ top 10 most popular stories of September 2021

Top stories for September...

Lankenau Heart Institute and Philips announced integrated cardiovascular solutions partnership

Royal Philips and Lankena...

FDA monitoring gender differences in outcomes with LAAO devices

The US Food and Drug Admi...
Tria

Enrolment completed in study of Tria aortic valve

Foldax has announced comp...
Cardiovascular Systems

First patient treated with Cardiovascular Systems’ ViperCross peripheral support catheter

Cardiovascular Systems re...

Siemens launches Luminos Impulse fluoroscopy system

Siemens Healthineers has ...

Abbott’s Amplatzer Talisman gains FDA approval

Abbott has announced that...
Orsiro Mission DES

Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent

Biotronik has announc...

Waiting list mortality for coronary procedures exacerbated during pandemic

Patients awaiting cor...

Open Stent Solution closes €2.5 funding round

Open Stent Solution (OSS)...

HRX digital health event moved to September 2022

The Heart Rhythm Society ...
CX Aortic Vienna

Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna

Capturing the latest deve...

ADVERTORIAL: Optimising TAVI device choice

This advertorial is spons...

“No red flags” for ticagrelor monotherapy according to stent type

 George Dangas (New Yor...

Neovasc to begin COSIRA-II trial of Reducer for refractory angina

Neovasc has announced tha...

FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement

Abbott has announced that...

Registry data show comparable outcomes for bicuspid and tricuspid TAVI in low-risk patients

Patients at low surgi...

Surgical team completes first implant of Aeson bioprosthetic heart in a female patient

A cardiothoracic surg...

Ultrasound guidance “should be routine” for transfemoral TAVI access

Ultrasound-guided tra...

Randomised trials needed to evaluate safety and efficacy of TMVR

Randomised trials are...

Abbott receives FDA approval for Portico with FlexNav TAVI system

Abbott has announced ...

OpSens receives Health Canada approval to begin clinical study of TAVI guidewire

OpSens has announced that...

Renal denervation: The most advanced and efficacious interventional approach to treat hypertension

Following the release...

Long-term preclinical results of Xeltis’ restorative CABG graft presented at ISACB 2021

One-year data from precli...

TCT 2021: Late-breaking trials programme announced

The Cardiovascular Re...

ESH position paper highlights renal denervation as a third option for hypertension management

European Society of Hyper...

Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system

Peijia Medical has an...

Christoph Naber

Christoph Naber (Essen, G...

New imaging technique has the potential to identify patients at high risk of aortic degeneration

Four-dimensional (4D)...

CytoSorbents files IDE for clinical trial of DrugSorb-ATR used during cardiothoracic surgery

CytoSorbents has filed an...

STENTiT makes trio of appointment to its medical advisory board

STENTiT, a medical de...

No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months

When a modified surgical ...

ABILITY Diabetes Global enrols thousandth patient

Concept Medical has annou...

Digital app speeds up time to STEMI care

“During a heart attac...

Cannabis use in younger adults linked to increased risk of myocardial infarction

Adults younger than 45 ye...
cardiovascular news top 10

Cardiovascular News’ top 10 most popular stories of August 2021

August’s top 10 features ...

HeartFlow announces enrolment of first three patients in FUSION trial

HeartFlow has announc...

ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS

Findings of the STOPD...

ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment

Abbott has announced ...
stroke risk factors

ESOC 2021: Non-traditional risk factors for heart attack and stroke rising more steeply in women

Work stress, sleep disord...

ESC 2021: One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI

 Marco Valgimigli...

ESC 2021: Systematic pressure wire assessment has no additional benefit at diagnostic angiography

Adding systematic fra...

MedAlliance announces first patient enrolment in SELUTION DeNovo study

MedAlliance today announc...

ESC 2021: TOMAHAWK trial does not support early coronary angiography in cardiac arrest without ST elevation

Early coronary angiog...

ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI

Edoxaban is noninferi...

ESC 2021: One-month dual antiplatelet therapy post-stent implant benefits high bleeding risk patients

One month of dual ant...

ESC 2021: Drones touted as the future of defibrillator delivery

The world’s first feasibi...

ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published

The European Society of C...

ESC 2021: Study charts impact of following health advice after a heart attack

Adherence to lifestyle ad...

Second hospital implants Aeson bioprosthetic artificial heart

CARMAT has announced the ...

Medtronic gains FDA approval for its latest-generation TAVI system

Medtronic has announced U...

ESC 2021: Family history outweighed by lifestyle choices in study of premature heart attacks

Young heart attack vi...

EMPOWER trial to study Carillon mitral contour system

Cardiac Dimensions ha...

Urgent TAVI patients more likely to be readmitted than elective cases

Readmissions within 3...

Cardiovascular News 62 – August 2021: OUS Edition

In this issue: Meta ...

Cardiovascular News 62 – August 2021: US Edition

In this issue: Meta ...

Ten-year outcomes of Yukon DES in diabetic patients published in JAHA

Translumina has announced...

Ultromics completes US$33 million Series B funding round

Ultromics, a developer of...

FDA grants breakthrough device designation to Impella ECP

The US Food and Drug ...
AI

Algorithm predicts heart failure hospitalisations

Biotronik has announced t...

Sinomed announces the first commercial implantation and European launch of the HT Supreme DES

Sinomed has announced...

App launched to cut time to treatment for STEMI patients

Physicians at Mount Sinai...

Second US FDA breakthrough device designation granted to CytoSorbents’ DrugSorb-ATR

CytoSorbents has been gra...

Abbott’s Amplatzer Amulet gains US FDA approval

Abbott has announced ...

Occlutech gains IDE approval for OCCLUFLEX pivotal study

Occlutech Holding has ann...

“Virtual contrast agent” could offer benefit in cardiac MRI assessment

An imaging technology dev...

Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform

Caption Health has an...

Women underrepresented in cardiovascular clinical trials

Women remain underreprese...

Realview Imaging gains FDA approval for Holoscope-i system

RealView Imaging has anno...

Back in the room: A welcome return to in-person education

With the COVID-19 pan...
cardiovascular news top 10

Cardiovascular News’ top 10 most popular stories of July 2021

Our top 10 stories of Jul...

Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19

The largest analysis ...

US launch for Abbott’s Ultreon AI-based coronary imaging platform

Abbott has announced that...

Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval

Edwards Lifesciences has ...

PCI procedures drop by 10% in USA since 2010, research suggests

The USA saw a 10% dec...

AngelMed launches its Guardian device in the USA

Angel Medical Systems (An...

TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure

An analysis of the ra...

Medtronic launches Prevail DCB in Europe

Medtronic has announced t...

ADVERTORIAL: DCB pioneer welcomes deliverability after first case with Medtronic’s brand new Prevail™ coronary DCB

This advertorial is spons...

CathWorks FFRangio system receives reimbursement approval in Japan

CathWorks has announc...

TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery

Among patients underg...

TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings

Clinical and economic...

TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year

Patients with bicuspi...

TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic stroke for Watchman FLX

Two-year results from the...

MedAlliance launches Origin balloons for vessel preparation

MedAlliance has launched ...

Ancora Heart secures US$80 million in financing

Ancora Heart has clos...

HeartFlow announces merger agreement

HeartFlow has entered...

First Aeson bioprosthetic artificial heart implanted in USA

Carmat has announced the ...

Pacemaker implantation after SAVR points to increased mortality and heart failure hospitalisation

Patients undergoing p...

First patients treated with reSept ASD occluder in IDE trial

atHeart Medical has a...

FDA approval for SafeCross transseptal RF system

East End Medical has ...
123...7Page 2 of 7

Most read

Features

Profiles

Bernardo Cortese

Roxana Mehran

Patrick Myers

Cardiovascular News

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube